Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study

Background and Objectives: Limited research focuses on the risk of ischemic cerebrovascular disease associated with use of dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) in patients with type 2 diabetes mellitus in Taiwan. This study aimed to investigate the association between DPP-4 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Shih-Wei, Liao, Kuan-Fu, Lin, Cheng-Li, Lin, Hsien-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702655/
https://www.ncbi.nlm.nih.gov/pubmed/29213240
http://dx.doi.org/10.3389/fphar.2017.00859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702655/
https://www.ncbi.nlm.nih.gov/pubmed/29213240
http://dx.doi.org/10.3389/fphar.2017.00859

Ejemplares similares